RMD - JPMorgan says time to buy MedTech based on past
2023-08-29 13:29:41 ET
More on IHI
- IHI: Too Expensive Considering Long-Term Rate Uncertainty
- Johnson & Johnson’s MedTech performance rallies industry
- Life science tools industry drags healthcare in S&P 500
- MedTech, hospital stocks slump after Texas Governor asked to delay elective procedures (Updated)
- FDA requests 8% increase in $6.5B FY 2022 budget request
- Seeking Alpha’s Quant Rating on iShares U.S. Medical Devices ETF
- Dividend scorecard for iShares U.S. Medical Devices ETF
For further details see:
JPMorgan says time to buy MedTech based on past